These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33706957)

  • 1. Relaxin abrogates genomic remodeling of the aged heart.
    Romero G; Salama G
    Vitam Horm; 2021; 115():419-448. PubMed ID: 33706957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin reverses inflammatory and immune signals in aged hearts.
    Martin B; Gabris-Weber BA; Reddy R; Romero G; Chattopadhyay A; Salama G
    PLoS One; 2018; 13(1):e0190935. PubMed ID: 29346407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.
    Parikh A; Patel D; McTiernan CF; Xiang W; Haney J; Yang L; Lin B; Kaplan AD; Bett GC; Rasmusson RL; Shroff SG; Schwartzman D; Salama G
    Circ Res; 2013 Jul; 113(3):313-21. PubMed ID: 23748429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels.
    Henry BL; Gabris B; Li Q; Martin B; Giannini M; Parikh A; Patel D; Haney J; Schwartzman DS; Shroff SG; Salama G
    Heart Rhythm; 2016 Apr; 13(4):983-91. PubMed ID: 26711798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin suppresses atrial fibrillation, reverses fibrosis and reduces inflammation in aged hearts.
    Romero G; Martin B; Gabris B; Salama G
    Biochem Pharmacol; 2024 Sep; 227():116407. PubMed ID: 38969298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin reverses maladaptive remodeling of the aged heart through Wnt-signaling.
    Martin B; Gabris B; Barakat AF; Henry BL; Giannini M; Reddy RP; Wang X; Romero G; Salama G
    Sci Rep; 2019 Dec; 9(1):18545. PubMed ID: 31811156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective actions of relaxin.
    Martin B; Romero G; Salama G
    Mol Cell Endocrinol; 2019 May; 487():45-53. PubMed ID: 30625345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding relaxin signalling at the cellular level.
    Valkovic AL; Bathgate RA; Samuel CS; Kocan M
    Mol Cell Endocrinol; 2019 May; 487():24-33. PubMed ID: 30592984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
    Chow BS; Kocan M; Bosnyak S; Sarwar M; Wigg B; Jones ES; Widdop RE; Summers RJ; Bathgate RA; Hewitson TD; Samuel CS
    Kidney Int; 2014 Jul; 86(1):75-85. PubMed ID: 24429402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties.
    Beiert T; Tiyerili V; Knappe V; Effelsberg V; Linhart M; Stöckigt F; Klein S; Schierwagen R; Trebicka J; Nickenig G; Schrickel JW; Andrié RP
    Biochem Biophys Res Commun; 2017 Aug; 490(3):643-649. PubMed ID: 28634079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
    Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
    Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology.
    Agoulnik IU; Kaftanovskaya EM; Myhr C; Bathgate RAD; Kocan M; Peng Y; Lindsay RM; DiStefano PS; Agoulnik AI
    Biochem Pharmacol; 2024 Sep; 227():116401. PubMed ID: 38945278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of relaxin on cardiac fibrosis, apoptosis, and tachyarrhythmia in rats with myocardial infarction.
    Wang D; Zhu H; Yang Q; Sun Y
    Biomed Pharmacother; 2016 Dec; 84():348-355. PubMed ID: 27668534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin Level in Patients With Atrial Fibrillation and Association with Heart Failure Occurrence: A STROBE Compliant Article.
    Zhou H; Qu X; Gao Z; Zheng G; Lin J; Su L; Huang Z; Li H; Huang W
    Medicine (Baltimore); 2016 May; 95(21):e3664. PubMed ID: 27227926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing relaxin receptor expression and exploring relaxin's effect on tissue remodeling/fibrosis in the human bladder.
    Diaz EC; Briggs M; Wen Y; Zhuang G; Wallace SL; Dobberfuhl AD; Kao CS; Chen BC
    BMC Urol; 2020 Apr; 20(1):44. PubMed ID: 32321501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodic injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts.
    Gabris-Weber B; Forghani R; Bernd Dschietzig T; Romero G; Salama G
    Biochem Pharmacol; 2024 May; 223():116136. PubMed ID: 38494063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.
    Conrad KP
    Hum Reprod Update; 2016 Sep; 22(5):647-64. PubMed ID: 27385360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease.
    Samuel CS; Lekgabe ED; Mookerjee I
    Adv Exp Med Biol; 2007; 612():88-103. PubMed ID: 18161483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.